
Saptrax TB 250mg/31.25mg Injection
Marketer
Sapson Pharma
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Saptrax TB 250mg/31.25mg Injection
Combiflox TB Injection (250mg/31.25mg) is a dual-action medication used to combat diverse bacterial infections. Its mechanism inhibits microbial proliferation, thus curbing infection spread. Administration must be under strict medical guidance. Consistent adherence to the prescribed treatment schedule is crucial; premature cessation may compromise its effectiveness. Complete the full course, even with symptom improvement. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe or worsening side effects necessitate immediate medical attention. Allergic reactions (skin rashes, itching, swelling, respiratory distress) demand prompt medical assistance. Inform your physician about all concurrent medications, particularly if pregnant or breastfeeding, before commencing treatment. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not affecting driving ability, refrain from operating vehicles if experiencing somnolence or dizziness. Rest, a nutritious diet, and ample hydration are vital for optimal recovery. Your doctor may order laboratory tests to monitor the medication's impact.
Primary Ingredients of Saptrax TB 250mg/31.25mg Injection
No text provided. Please provide the text you would like me to rephrase.
Uses of Saptrax TB 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Saptrax TB 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Saptrax TB 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Saptrax TB 250mg/31.25mg Injection:
Administering this medication will be handled by your healthcare provider. Please do not attempt self-medication.
How Saptrax TB 250mg/31.25mg Injection works:
Ceftriaxone/Tazobactam (Saptrax TB 250mg/31.25mg Injection) combines a cephalosporin antibiotic, Ceftriaxone, with a beta-lactamase inhibitor, Tazobactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering bacterial survival. Tazobactam counters bacterial resistance mechanisms, thereby bolstering Ceftriaxone's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Saptrax TB 250mg/31.25mg Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Saptrax TB, containing 250mg/31.25mg, is typically deemed safe for use in pregnant individuals. Preclinical trials in animals revealed minimal or no harm to the fetus; nevertheless, data from human clinical trials are scarce.
Breast feedingCAUTION
The administration of Saptrax TB 250mg/31.25mg Injection necessitates prudence while breastfeeding. Mothers should discontinue breastfeeding throughout their treatment course and until the medication is fully cleared from their system.
DrivingUNSAFE
The administration of Saptrax TB 250mg/31.25mg Injection can cause drowsiness, blurred vision, and dizziness. Refrain from operating a vehicle if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Saptrax TB 250mg/31.25mg Injection to individuals with impaired renal function. Physician consultation is advised.
LiverCAUTION
Caution is advised when administering Saptrax TB 250mg/31.25mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. A physician's consultation is recommended. Dosage alteration for Saptrax TB 250mg/31.25mg Injection is unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Saptrax TB 250mg/31.25mg Injection :
Should you inadvertently omit a dose of Saptrax TB 250mg/31.25mg Injection, seek medical advice.
Facts to Know About Saptrax TB 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-Infective Agents |
